| scholarly article | Q13442814 |
| P2093 | author name string | A Massumi | |
| R J Hall | |||
| M Harlan | |||
| J J Seger | |||
| I J Mas | |||
| P2860 | cites work | Clinical efficacy of amiodarone as an antiarrhythmic agent | Q28329369 |
| Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia | Q33170141 | ||
| Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias | Q33173226 | ||
| Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects | Q40172905 | ||
| Effects of amiodarone on thyroid function in patients with ischaemic heart disease | Q41325474 | ||
| Side effects and complications of amiodarone therapy | Q42209574 | ||
| Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients | Q42245850 | ||
| Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias | Q42254976 | ||
| Amiodarone-induced ventricular fibrillation. | Q42272547 | ||
| Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone | Q44255254 | ||
| Amiodarone and desethylamiodarone distribution in the atrium and adipose tissue of patients undergoing short- and long-term treatment with amiodarone | Q45041480 | ||
| Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation. | Q50927091 | ||
| Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. | Q50937859 | ||
| Effects of amiodarone and L8040, novel antianginal and antiarrhythmic drugs, on cardiac and coronary haemodynamics and on cardiac intracellular potentials. | Q54161987 | ||
| QT prolongation and arrhythmia suppression | Q69380557 | ||
| Amiodarone: risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study | Q69960739 | ||
| QT prolongation and the antiarrhythmic efficacy of amiodarone | Q69990654 | ||
| Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease | Q70055127 | ||
| Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachy | Q70361787 | ||
| Ventricular arrhythmias: use of electrophysiologic studies | Q71019712 | ||
| Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias | Q71024651 | ||
| Effects of intravenous amiodarone in patients with inducible repetitive ventricular responses and ventricular tachycardia | Q71344531 | ||
| Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone | Q71379455 | ||
| Effect of amiodarone on conduction and refractoriness of the His-Purkinje system in the human heart | Q71395153 | ||
| P433 | issue | 4 | |
| P921 | main subject | amiodarone | Q410061 |
| P304 | page(s) | 382-388 | |
| P577 | publication date | 1987-12-01 | |
| P1433 | published in | Texas Heart Institute Journal | Q26841976 |
| P1476 | title | Electrophysiologic testing: predictive of amiodarone efficacy in recurrent sustained ventricular tachycardia? | |
| P478 | volume | 14 |
| Q35313411 | Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias | cites work | P2860 |
Search more.